The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, producing billions in income, its exclusivity period created a flood of generic competition , significantly eroding its position . While specific firms may attempt to capitalize on male sexual dysfunction, the existing land